Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
The coronavirus pandemic, COVID-19 has a global impact on the lives and livelihoods of people. It is characterized by a widespread infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), where infected patients may develop serious medical complications or even face death. Deve...
Saved in:
Main Authors: | Tan, Rebecca Shu Ling, Hassandarvish, Pouya, Chee, Chin Fei, Chan, Lai Wah, Wong, Tin Wui |
---|---|
Format: | Article |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/42269/ https://doi.org/10.1016/j.carbpol.2022.119500 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chitosan as therapeutical excipient in cancer nanomedicine development / Wong Tin Wui
by: Wui, Wong Tin
Published: (2024) -
Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
by: Chan, Lee-Chin, et al.
Published: (2023) -
Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020) -
Anti-SARS-CoV-2 biotherapeutics and chemotherapeutics: An insight into product specifications and marketing dynamics
by: Kotra, Vijay, et al.
Published: (2022) -
Anti-SARS-CoV-2 Biotherapeutics and Chemotherapeutics: An Insight into Product Specifications and Marketing Dynamics
by: Vijay, Kotra, et al.
Published: (2022)